Healthcare Global Enterprises (HCG) Share Price falls 5.17% as HCG trades lower
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Healthcare Global Enterprises Share Price is in focus after HCG slipped 5.17% to Rs 665.15 on 30 September 2026 at 3:33:26 PM IST. The company’s market capitalisation stood at Rs 10,336.94 crore, placing it in the Mid Cap category. According to Univest data, the move keeps Healthcare Global Enterprises Share Price under active attention because the decline came after a higher opening and a brief move above the previous close, before the stock moved lower within the day’s range. Since no company-specific catalyst is established, the verified price action and the valuation backdrop are the main points to track in Healthcare Global Enterprises Stock News today.
For readers tracking Healthcare Global Enterprises Share Price Today, the latest session shows a move from Rs 701.45 at the previous close to Rs 665.15, a decline of Rs 36.30. The stock opened at Rs 693.85, touched a high of Rs 703.50 and a low of Rs 662.25. That keeps the day’s movement firmly within intraday price action rather than a longer trend story. In Univest coverage, the stock remains relevant because the combination of a sharp price fall and a high valuation multiple naturally draws attention to Healthcare Global Enterprises Share Price and Healthcare Global Enterprises Share Price news.
Healthcare Global Enterprises (HCG) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 665.15 |
| Previous Close | Rs 701.45 |
| Today's Move | -Rs 36.30 (-5.17%) |
| Open | Rs 693.85 |
| High | Rs 703.5 |
| Low | Rs 662.25 |
| Market Capitalisation | Rs 10,336.94 crore |
| Market Cap Category | Mid Cap |
Healthcare Global Enterprises Share Price traded at Rs 665.15 as of 30 September 2026 at 3:33:26 PM IST, versus a previous close of Rs 701.45. That is a Rs 36.30 decline, or 5.17%, in the latest session. The day opened at Rs 693.85, rose to Rs 703.50, and then moved down to a low of Rs 662.25. The market capitalisation of Rs 10,336.94 crore keeps Healthcare Global Enterprises in the Mid Cap category, which is the correct size context for this HCG Share Price move. The gap between the day’s high and low shows that the stock moved through a fairly wide intraday band before settling near the lower end of the range. For Healthcare Global Enterprises Share Price Today, the key fact is the decline itself; according to Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes price action the starting point for any Healthcare Global Enterprises Share Price analysis, before moving to fundamentals.
Healthcare Global Enterprises (HCG) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 10,336.94 crore |
| P/E Ratio | 459.74x |
| P/B Ratio | 7.77x |
| ROE | 2.04% |
| ROCE | 9.77% |
| EPS | Rs 1.53 |
| Book Value Per Share | Rs 90.25 |
| Dividend Yield | 0% |
Healthcare Global Enterprises (HCG) fundamental metrics show P/E 459.74x, P/B 7.77x, ROE 2.04%, ROCE 9.77%. These ratios show where the company stands today and are not a call to buy or sell.
Healthcare Global Enterprises has a market capitalisation of Rs 10,336.94 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 459.74x, P/B at 7.77x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 2.04% and ROCE of 9.77%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 1.53, book value per share of Rs 90.25, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 46.9x, median ROE of 13.01%, median ROCE of 15.84%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 459.74x |
| Benchmark Median P/E | 46.9x |
| Benchmark Average P/E | 100.02x |
| Benchmark P/E Range | 6.8x to 1,572.9x |
| Company P/B Ratio | 7.77x |
| Benchmark Median P/B | 3.88x |
| Benchmark Average P/B | 4.71x |
| Company ROE | 2.04% |
| Benchmark Median ROE | 13.01% |
| Benchmark Average ROE | 12.87% |
| Company ROCE | 9.77% |
| Benchmark Median ROCE | 15.84% |
| Benchmark Average ROCE | 2.83% |
| Company Market Capitalisation | Rs 10,336.94 crore |
| Benchmark Median Market Cap | Rs 578.29 crore |
| Benchmark Average Market Cap | Rs 11,352.34 crore |
Healthcare Global Enterprises (HCG) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.
Healthcare Global Enterprises (HCG) has a P/E ratio of 459.74x, which is above the benchmark median of 46.9x, a difference of +880.26%. A P/E difference of this kind is a reference point rather than a recommendation.
Healthcare Global Enterprises (HCG) has a ROE of 2.04%, which is below the benchmark median of 13.01%, a difference of -84.32%. Healthcare Global Enterprises (HCG) has a ROCE of 9.77%, which is below the benchmark median of 15.84%, a difference of -38.32%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | APOLLOHOSP | 1,27,421.96 | 59.88 | 12.92 | 23.54 | 21.73 |
| Max Healthcare Institute | MAXHEALTH | 97,418.62 | 65.73 | 8.76 | 14.53 | 14.97 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 94,970.23 | 110.4 | 5.4 | 12.95 | 13.93 |
| Aster DM Healthcare | ASTERDM | 65,183.66 | 201.12 | 15.15 | 13.07 | 16.22 |
| Fortis Healthcare | FORTIS | 62,782.32 | 59.01 | 6.08 | 11.32 | 14.07 |
Healthcare Global Enterprises (HCG) has a P/E ratio of 459.74x compared with the displayed peer median of 65.73x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 2.04% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 9.77% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Healthcare Global Enterprises (HCG) has a market capitalisation of Rs 10,336.94 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Healthcare Global Enterprises Share Price
- Healthcare Global Enterprises Share Price fell 5.17%, so the latest intraday move itself is the first point investors are tracking.
- The stock’s P/E of 459.74 keeps Healthcare Global Enterprises Stock News centred on valuation in the healthcare space.
- ROE of 2.04% and ROCE of 9.77% place the Healthcare Global Enterprises Share Price discussion in a return-quality context.
- Market capitalisation of Rs 10,336.94 crore keeps HCG in the Mid Cap category and supports stock-specific comparisons.
- The company’s P/B of 7.77 and EPS of Rs 1.53 give additional context for Healthcare Global Enterprises Share Price analysis.
About Healthcare Global Enterprises
Healthcare Global Enterprises Share Price belongs to Healthcare Global Enterprises, a company in the Healthcare sector and the Hospital & Healthcare Services industry. The business context in this article is to the verified sector and industry details available here, so the focus remains on its listed market metrics. Investors watching Healthcare Global Enterprises Share Price Today are looking at a healthcare operator whose market value, profitability ratios and valuation multiple are all part of the current discussion. The company’s position in a broad hospital-services peer set makes it relevant for sector analysis, especially when the stock’s daily move is large enough to stand out in Healthcare Global Enterprises Stock News.
Track Healthcare Global Enterprises Share Price on Univest
Use Healthcare Global Enterprises (HCG) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Healthcare Global Enterprises Share Price can be followed on Univest for live share price updates, fundamental ratios, market capitalisation, 52-week levels and market insights. Univest also helps readers track HCG Share Price, valuation context and peer comparison in one place. For users watching Healthcare Global Enterprises Share Price Today, the combination of price action, sector context and return ratios offers a practical starting point for further monitoring.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Healthcare Global Enterprises Share Price falling today?
Ans. Healthcare Global Enterprises Share Price fell 5.17% to Rs 665.15. The price move is confirmed in Univest data; a company-specific reason has not been established. The move followed a previous close of Rs 701.45 and stayed within the day’s intraday.
What is Healthcare Global Enterprises Share Price today?
Ans. Healthcare Global Enterprises Share Price was Rs 665.15 as of 30 September 2026 at 3:33:26 PM IST. The stock traded below its previous close of Rs 701.45 after touching a high of Rs 703.50 and a low of Rs 662.25.
How much did HCG share price fall?
Ans. HCG share price fell by Rs 36.30, which is 5.17%, in the latest session. That move took Healthcare Global Enterprises Share Price from Rs 701.45 at the previous close to Rs 665.15 during the trading day.
What is the market cap of Healthcare Global Enterprises?
Ans. Healthcare Global Enterprises had a market capitalisation of Rs 10,336.94 crore. It falls in the Mid Cap category, which is the right size context for comparing Healthcare Global Enterprises Share Price with healthcare peers and sector benchmarks.
Is Healthcare Global Enterprises Share Price expensive?
Ans. On the latest Univest figures, Healthcare Global Enterprises Share Price trades at a P/E of 459.74 and P/B of 7.77. Both are above the sector median, so the valuation looks rich relative to the hospital-services benchmark.
How does HCG compare with healthcare peers?
Ans. HCG’s P/E of 459.74 is well above peers such as Apollo Hospitals at 59.88 and Fortis at 59.01. Its ROE of 2.04% is also below most listed healthcare peers in the comparison set.
What do EPS and book value tell about Healthcare Global Enterprises Share Price?
Ans. EPS of Rs 1.53 shows earnings attributable to each share, while book value of Rs 90.25 shows the accounting net worth behind each share. Together they help explain how Healthcare Global Enterprises Share Price is being valued.
Should investors track Healthcare Global Enterprises Share Price on Univest?
Ans. Yes. Univest lets readers track Healthcare Global Enterprises Share Price, valuation ratios, market capitalisation and sector context in one place. That makes it useful for monitoring HCG Share Price news, price action and peer comparison over time.
